Related Experiment Video
Updated: Apr 18, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma
1Orthopedics Department, The Affiliated Hospital to Changchun University of Chinese Medicine, No.1478 of Gongnong Street, Chaoyang District, Changchun, 130021, China, xiaojianglicc@163.com.
Abstract:
JMJD2B and JMJD2C, histone demethylases, play crucial roles in cancer development and are up-regulated in many cancers. However, the actions of JMJD2B and JMJD2C in osteosarcoma remain unknown. The levels of JMJD2B or JMJD2C were evaluated in osteosarcoma cells and tissues via quantitative real-time PCR and Western Blot. JMJD2B and JMJD2C were up-regulated in osteosarcoma tissues when compared to paired adjacent non-tumor tissues. A higher level of JMJD2B or JMJD2C was related with metastasis of osteosarcoma cells. Fibroblast growth factor 2 (FGF2) is an important factor to maintain immaturity of cells and contributes to osteosarcoma aggressiveness. Elevated levels of FGF2 promoted the proliferation, migration, and invasion of osteosarcoma cell, while FGF2 was up-regulated by JMJD2B or JMJD2C. GST pull-down assay showed that JMJD2B or JMJD2C interacted with FGF2. Thus, JMJD2B and JMJD2C play an important role in the pathology of osteosarcoma via the up-regulation of FGF2. JMJD2B and JMJD2C should be developed potential targets for the therapy of osteosarcoma patients.
Insights
Histone demethylases JMJD2B and JMJD2C are elevated in osteosarcoma, promoting cancer progression by up-regulating Fibroblast Growth Factor 2 (FGF2). Targeting JMJD2B and JMJD2C may offer new osteosarcoma therapies.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Histone demethylases JMJD2B and JMJD2C are implicated in various cancers.
- Their specific roles in osteosarcoma pathogenesis are not well understood.
- Osteosarcoma aggressiveness is linked to factors like Fibroblast Growth Factor 2 (FGF2).
Purpose of the Study:
- To investigate the expression and function of JMJD2B and JMJD2C in osteosarcoma.
- To determine the relationship between JMJD2B/JMJD2C and osteosarcoma cell behavior.
- To elucidate the molecular mechanism involving JMJD2B/JMJD2C and FGF2 in osteosarcoma.
Main Methods:
- Quantitative real-time PCR and Western Blotting to assess JMJD2B/JMJD2C levels.
- Analysis of JMJD2B/JMJD2C expression in osteosarcoma tissues versus adjacent non-tumor tissues.
- GST pull-down assays to confirm protein interactions.
Main Results:
- JMJD2B and JMJD2C expression was significantly higher in osteosarcoma tissues compared to normal tissues.
- Elevated JMJD2B/JMJD2C levels correlated with increased osteosarcoma cell metastasis.
- JMJD2B/JMJD2C directly up-regulated FGF2, which in turn promoted osteosarcoma cell proliferation, migration, and invasion.
Conclusions:
- JMJD2B and JMJD2C play a critical role in osteosarcoma progression through the FGF2 pathway.
- These histone demethylases are potential therapeutic targets for osteosarcoma treatment.
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Induced Pluripotent Stem Cells
Somatic...
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

